Salivary matrix metalloproteinase-8 and -9 and myeloperoxidase in relation to coronary heart and periodontal diseases: A subgroup report from the PAROKRANK study (Periodontitis and its relation to coronary artery disease)

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Nilminie, Rathnayake ^a   Anders, Gustafsson ^a   Anna, Norhammar ^b   Barbro, Kjellström ^b   Björn, Klinge ^a,d   Lars, Rydén ^b   Taina, Tervahartiala ^c   Timo, Sorsa ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; BIOLOGICAL MARKER; PEROXIDASE;

AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; IMMUNOFLUORESCENCE TEST; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIODONTAL DISEASE; SALIVA ANALYSIS; SALIVA LEVEL; SEX DIFFERENCE; WESTERN BLOTTING; CHRONIC PERIODONTITIS; COMORBIDITY; COMPLICATION; ENZYMOLOGY; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTOR; SALIVA;

AGED; BIOMARKERS; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; PEROXIDASE; RISK FACTORS; SALIVA; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84940391482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126370     Document Type: Article

References (43)

1. Richards D (2014) Review finds that severe periodontitis affects 11% of the world population. Evid Based Dent 15:70-71. doi: 10.1038/sj.ebd.6401037 PMID: 25343387
2. Hugoson A, Norderyd O (2008) Has the prevalence of periodontitis changed during the last 30 years? J Clin Periodontol 35:338-345. doi: 10.1111/j.1600-051X.2008.01279.x PMID: 18724861
3. Bahekar AA, Singh S, Saha S, Molnar J, Arora R (2007) The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 154:830-837. PMID: 17967586
4. Uitto VJ, Overvall Cm, McCulloch C (2003) Proteolytic host enzymes in gingival crevicular fluid. Periodontol 2000 31:77-104. PMID: 12656997
5. Amalinei C, Caruntu ID, Ginsca SE, Balan RA (2010) Matrix metalloproteinase involvement in pathological condition. Rom J Morphol Embryol 52:215-228.
6. Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160. PMID: 9165065
7. Verstappen J, Von den Hoff JW (2006) Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J Dent Res 85:1074-1084. PMID: 17122157
8. Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. (2006) Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 38:306-321. PMID: 16938801
9. Lenglet S, Mach F, Montecucco F (2013) Role of matrix metalloproteinase-8 in atherosclerosis. Mediators Inflamm 659282. doi: 10.1155/2013/659282 PMID: 23365489
10. Herman MP, Sukhova GK, Libby P, Gerdes N, Tang N, Horton DB, et al. (2001) Expression of neutrophil collagenese (matrix metalloproteinase-8) in human artheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104:1899-1904. PMID: 11602491
11. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, et al. (2002) Neutrophil infiltration of culpit lesions in acute coronary syndromes. Circulation 106:2894-2900. PMID: 12460868
12. Tschesche H, Haerian A, Kinane DF, Konttinen YT, Sorsa T (1996) Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 23:1127-1132. PMID: 8997658
13. Meschiari CA, Marcaccini AM, Santos Moura BC, Zuardi LR, Tanus-Santos JE, Gerlach RF (2013) Salivary MMPs, TIMPs, and MPO levels in periodontal disease patients and controls. Clin Chim Acta 421:140-146. doi: 10.1016/j.cca.2013.03.008 PMID: 23501330
14. Gursoy UK, Könönen E, Huumonen S, Tervahartiala T, Pussinen PJ, Suominen AL, et al. (2013) Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis. J Clin Periodontol 40:18-25. doi: 10.1111/jcpe.12020 PMID: 23078613
15. Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML (2013) Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology (Bethesda) 28:391-403. doi: 10.1152/physiol.00029.2013 PMID: 24186934
16. Leppilahti JM, Hernández-Ríos PA, Gamonal JA, Tervahartiala T, Brignardello-Petersen R, Mantyla P, et al. (2014) Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide sitespecific diagnostic value for chronic periodontitis. J Clin Periodontol 41:348-56. doi: 10.1111/jcpe.12223 PMID: 24382144
17. Saari H, Suomalainen K, Lindy O, Konttinen YT, Sorsa T (1990) Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases. Biochem Biophys Res Commun 171:979-987. PMID: 2171513
18. Spallarossa P, Garibaldi S, Barisione C, Ghigliotti G, Altieri P, Tracchi I, et al. (2008) Postprandial serum induces apoptosis in endothelial cells: Role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity. Atherosclerosis 198:458-467. doi: 10.1016/j.atherosclerosis.2007.11.030 PMID: 18177875
19. Ikitimur B, Karadag B (2010) Role of myeloperoxidase in cardiology. Future Cardiol 6:693-702. doi: 10.2217/fca.10.75 PMID: 20932115
20. Loria V, Dato I, Graziani F, Biasucci LM (2008) Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 135625. doi: 10.1155/2008/135625 PMID: 18382609
21. Smith QT, Hinrichs JE, Melnyk RS (1986) Gingival crevicular fluid myeloperoxidase at periodontitis sites. J. Periodontal Research 21:45-55. PMID: 3007721
22. Sakamoto W, Fujii Y, Kanehira T, Asano K, Izumi H (2008) A novel assay system for myeloperoxidase activity in whole saliva. Clin Biochem 41:584-590. doi: 10.1016/j.clinbiochem.2007.12.025 PMID: 18237554
23. Thygesen K, Alpert JS, White HD: on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) Universal definition of myocardial infarction. Circulation 116:2634-2653. PMID: 17951284
24. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction (2012) Third Universal Definition of Myocardial Infarction. Circulation 126:2020-2035. doi: 10.1161/CIR.0b013e31826e1058 PMID: 22923432
25. Hemmilä I, Dakubu S, Mukkala VM, Siitari H, Lovgren T (1984) Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 137: 335-343. PMID: 6375455
26. Rautelin HI, Oksanen AM, Veijola LI, Sipponen PI, Tervahartiala TI, Sorsa TA, et al. (2009) Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis. Ann Med 41:208-215. doi: 10.1080/07853890802482452 PMID: 18979291
27. Buduneli E, Mäntylä P, Emingil G, Tervahartiala T, Pussinen P, Bariş N, et al. (2011) Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level. J Periodontol 82:716-725. doi: 10.1902/jop.2010.100492 PMID: 21091346
28. Furuholm J, Sorsa T, Qvarnström M, Janket SJ, Tervahartiala T, Nuutinen P, et al. (2006) Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease. J Periodontal Res 41:486-489. PMID: 16953826
29. Yokota T, Osanai T, Hanada K, Kushibiki M, Abe N, Oikawa K, et al. (2010) Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril. Heart Vessels 25:460-468. doi: 10.1007/s00380-010-0013-4 PMID: 20922537
30. Guan W, Kozak A, Fagan SC (2011) Drug repurposing for vascular protection after acute ischemic stroke. Acta Neurochir Suppl 111:295-308. doi: 10.1007/978-3-7091-0693-8-49 PMID: 21725771
31. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, et al. (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55-62. PMID: 10880048
32. Meschiari CA, Marcaccini AM, Santos Moura BC, Zuardi LR, Tanus-Santos JE, Gerlach RF (2013) Salivary MMPs, TIMPs, and MPO levels in periodontal disease patients and controls. Clin Chim Acta 5:140-146.
33. Palm F, Lahdentausta L, Sorsa T, Tervahartiala T, Gokel P, Buggle F, et al. (2013) Biomarkers of periodontitis and inflammation in ischemic stroke: A case-control study. Innate Immun 17:511-518.
34. Yamamoto D, Takai S (2009) Pharmacological implications of MMP-9 inhibition by ACE inhibitors. Curr Med Chem 16:1349-1354. PMID: 19355890
35. Rugina M, Caras I, Jurcut R, Jurcut C, Serbanescu F, Salageanu A, et al. (2007) Systemic inflammatory markers in patients with aortic sclerosis. Roum Arch Microbiol Immunol 66:10-16. PMID: 18928057
36. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, et al. (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1135-1142. PMID: 10502816
37. Schindhelm RK, van der Zwan LP, Teerlink T, Scheffer PG (2009) Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clin Chem 55:1462-70. doi: 10.1373/clinchem.2009.126029 Epub 2009 Jun 25. PMID: 19556446
38. Hernandez M, Gamonal J, Tervahartiala T, Mäntylä P, Rivera O, Dezerega A, et al. (2010) Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: A Longitudinal Study. J. Periodontol 81:1644-1652. doi: 10.1902/jop.2010.100196 PMID: 20653434
39. Sorsa T, Tervahartiala T, Leppilahti J, Hernandez M, Gamonal J, Tuomainen AM, et al. (2011) Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res 63:108-113. doi: 10.1016/j.phrs.2010.10.005 PMID: 20937384
40. Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, et al. (2013) Salivary biomarkers of oral health: a cross-sectional study. J Clin Periodontol 40:140-147. doi: 10.1111/jcpe.12038 PMID: 23174014
41. Mäntylä P, Buduneli E, Emingil G, Tervahartiala T, Pussinen PJ, Bariş N, et al. (2012) Acute myocardial infarction elevates serine protease activity in saliva of patients with periodontitis. J Periodontal Res 47:345-353. doi: 10.1111/j.1600-0765.2011.01439.x PMID: 22181012
42. Mäntylä P, Stenman M, Kinane D, Salo T, Suomalainen K, Tikanoja S, et al. (2006) Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res 41:503-512. PMID: 17076774
43. Gomes SC, Piccinin FB, Oppermann RV, Susin C, Marcantonio RA (2009) The effect of smoking on gingival crevicular fluid volume during the treatment of gingivitis. Acta Odontol Latinoam 22: 201-206. PMID: 20302219